Chugai Pharmaceutical (CHGCY)
Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, sale, importation, and exportation of pharma...
- Open
- 22.110
- High
- 22.380
- Low
- 21.860
- Prev. Close
- 21.660
- Volume
- 418.99K
- Turnover
- 9.29M
- Avg Price
- 22.178
- Bid/Ask Ratio
- --
- Amplitude
- 2.40%
- 52wk High
- 34.840
- Volume Ratio
- 1.25
- Turnover Ratio
- 0.03%
News
- Pharmaceutical Business Review · Aug 5 at 04:16 AM
Phylo and Chugai collaborate to deploy AI platform in drug discovery
- PUBT · Jul 31 at 01:32 AM
Chugai seeks Japan approval for Enspryng to prevent MOGAD relapses
- PUBT · Jul 27 at 03:54 AM
Chugai posts transcript of FY2026 Q2 financial results conference call
- businessinsider · Jul 24 at 04:14 AM
Chugai Pharmaceutical reports 1H results
- Quartr · Jul 24 at 02:01 AM
Chugai Pharmaceutical : Double-digit revenue and profit growth driven by strong sales and robust pipeline progress
- Fiercepharma · Jul 10 at 03:17 AM
Sobi tops bleeding disorder patient groups' reputation rankings
